LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, DellaRocca C (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8(1):39–51. https://doi.org/10.1016/0169-6009(91)90139-q

Article  PubMed  CAS  Google Scholar 

Laan RF, van Riel PL, van de Putte LB, van Erning LJ, MA, Hof, JA, Lemmens (1993) Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis A randomized, controlled study. Ann Int Med 119(10):963–968. https://doi.org/10.7326/0003-4819-119-10-199311150-00001

Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15(4):323–328. https://doi.org/10.1007/s00198-003-1548-3

Article  PubMed  CAS  Google Scholar 

Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton IL, Tenenhouse A, Reeve J, Silman AJ, Pols HA, Eisman JA, McCloskey EV, Mellstrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19(6):893–899. https://doi.org/10.1359/jbmr.040134

Article  PubMed  Google Scholar 

Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11(7):556–561. https://doi.org/10.1007/s001980070075

Article  PubMed  CAS  Google Scholar 

Peeters CM, Visser E, Van de Ree CL, Gosens T, Den Oudsten BL, De Vries J (2016) Quality of life after hip fracture in the elderly: a systematic literature review. Injury 47(7):1369–1382. https://doi.org/10.1016/j.injury.2016.04.018

Article  PubMed  Google Scholar 

Buckley L, Humphrey MB (2018) Glucocorticoid-induced osteoporosis. N Engl J Med 379(26):2547–2556. https://doi.org/10.1056/NEJMcp1800214

Article  PubMed  Google Scholar 

Chotiyarnwong P, McCloskey EV (2020) Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol 16(8):437–447. https://doi.org/10.1038/s41574-020-0341-0

Article  PubMed  Google Scholar 

van Staa TPLH, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39:1383–1389

Article  PubMed  Google Scholar 

Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15(6):993–1000. https://doi.org/10.1359/jbmr.2000.15.6.993

Article  PubMed  Google Scholar 

Balasubramanian A, Wade SW, Adler RA, Lin CJF, Maricic M, O’Malley CD, Saag K, Curtis JR (2016) Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int 27(11):3239–3249. https://doi.org/10.1007/s00198-016-3646-z

Article  PubMed  CAS  Google Scholar 

Matsuda S, Fujimori K (2012) The claim database in Japan. Asian Pac J Dis Manag 6(3–4):55–59

Google Scholar 

Japanese Ministry of Health Labour, and Welfare (2016) Proportion of electronic claims in the Japanese health insurance system. Japanese Ministry of Health, Labour, and Welfare. https://www.mhlw.go.jp/file/06-Seisakujouhou-12400000-Hokenkyoku/0000099002.pdf. Accessed 14 June 2021

Japanese Ministry of Health Labour, and Welfare (2017) NDB open data. Japanese Ministry of Health, Labour, and Welfare. https://www.mhlw.go.jp/file/06-Seisakujouhou-12400000-Hokenkyoku/0000193322.pdf. Accessed 14 June 2021

Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H (2013) A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 9(1):30. https://doi.org/10.1186/1710-1492-9-30

Article  PubMed  PubMed Central  Google Scholar 

Tamaki J, Fujimori K, Ikehara S, Kamiya K, Nakatoh S, Okimoto N, Ogawa S, Ishii S, Iki M (2019) Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012–2015. Osteoporos Int 30(5):975–983. https://doi.org/10.1007/s00198-019-04844-8

Article  PubMed  CAS  Google Scholar 

Hudson M, Avina-Zubieta A, Lacaille D, Bernatsky S, Lix L, Jean S (2013) The validity of administrative data to identify hip fractures is high–a systematic review. J Clin Epidemiol 66(3):278–285. https://doi.org/10.1016/j.jclinepi.2012.10.004

Article  PubMed  Google Scholar 

Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, Humphrey MB, Lane NE, Magrey M, Miller M, Morrison L, Rao M, Robinson AB, Saha S, Wolver S, Bannuru RR, Vaysbrot E, Osani M, Turgunbaev M, Miller AS, McAlindon T (2017) 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol 69(8):1521–1537. https://doi.org/10.1002/art.40137

Article  PubMed  Google Scholar 

Suzuki Y, Nawata H, Soen S, Fujiwara S, Nakayama H, Tanaka I, Ozono K, Sagawa A, Takayanagi R, Tanaka H, Miki T, Masunari N, Tanaka Y (2014) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. J Bone Miner Metab 32(4):337–350. https://doi.org/10.1007/s00774-014-0586-6

Article  PubMed  Google Scholar 

Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis JA, McCloskey EV, Poole KES, Reid DM, Selby P, Thompson F, Thurston A, Vine N (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12(1):43. https://doi.org/10.1007/s11657-017-0324-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW (2007) EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 66(12):1560–1567. https://doi.org/10.1136/ard.2007.072157

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgström F, Cooper C, Diez Perez A, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23(9):2257–2276. https://doi.org/10.1007/s00198-012-1958-1

Article  PubMed  CAS  Google Scholar 

Balasubramanian A, Wade SW, Adler RA, Saag K, Pannacciulli N, Curtis JR (2018) Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions. J Bone Miner Res 33(10):1881–1888. https://doi.org/10.1002/jbmr.3523

Article  PubMed  CAS  Google Scholar 

van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13(10):777–787. https://doi.org/10.1007/s001980200108

Article  PubMed  Google Scholar 

Ikeda S, Morishita Y, Tsutsumi H, Ito M, Shiraishi A, Arita S, Akahoshi S, Narusawa K, Nakamura T (2003) Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs. Bone 33(5):779–787. https://doi.org/10.1016/s8756-3282(03)00263-1

Article  PubMed  CAS  Google Scholar 

Kyriacou DN, Lewis RJ (2016) Confounding by indication in clinical research. JAMA 316(17):1818–1819. https://doi.org/10.1001/jama.2016.16435

Article  PubMed  Google Scholar 

The Japanese Orthopaedic Association (2019) Results of national survey of hip fracture in 2019. https://www.joa.or.jp/member/committee/osteoporosis/pdf/femur19.pdf. Accessed 7 May 2021

Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ 3rd (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 7(2):221–227. https://doi.org/10.1002/jbmr.5650070214

Article  PubMed  CAS  Google Scholar